2025-02-01 2026-01-31 false Capium Accounts Production 1.1 12411051 2025-02-01 2026-01-31 12411051 bus:FullAccounts 2025-02-01 2026-01-31 12411051 bus:FRS102 2025-02-01 2026-01-31 12411051 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 12411051 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 12411051 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 12411051 2025-02-01 2026-01-31 12411051 2026-01-31 12411051 bus:RegisteredOffice 2025-02-01 2026-01-31 12411051 core:WithinOneYear 2026-01-31 12411051 core:AfterOneYear 2026-01-31 12411051 1 2025-02-01 2026-01-31 12411051 bus:Director1 2025-02-01 2026-01-31 12411051 bus:Director1 2026-01-31 12411051 bus:Director1 2024-02-01 2025-01-31 12411051 bus:Director2 2025-02-01 2026-01-31 12411051 bus:Director2 2026-01-31 12411051 bus:Director2 2024-02-01 2025-01-31 12411051 2024-02-01 12411051 bus:LeadAgentIfApplicable 2025-02-01 2026-01-31 12411051 2024-02-01 2025-01-31 12411051 2025-01-31 12411051 core:WithinOneYear 2025-01-31 12411051 core:AfterOneYear 2025-01-31 12411051 bus:EntityAccountantsOrAuditors 2024-02-01 2025-01-31 12411051 bus:OrdinaryShareClass1 2025-02-01 2026-01-31 12411051 bus:OrdinaryShareClass1 2026-01-31 12411051 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 12411051 bus:OrdinaryShareClass1 2025-01-31 12411051 core:MotorCars 2025-02-01 2026-01-31 12411051 core:MotorCars 2026-01-31 12411051 core:MotorCars 2025-01-31 12411051 core:ComputerEquipment 2025-02-01 2026-01-31 12411051 core:ComputerEquipment 2026-01-31 12411051 core:ComputerEquipment 2025-01-31 12411051 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-01-31 12411051 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 12411051 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 12411051 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 12411051 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 12411051 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 12411051 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 12411051 core:Non-currentFinancialInstruments 2026-01-31 12411051 core:Non-currentFinancialInstruments 2025-01-31 12411051 core:ShareCapital 2026-01-31 12411051 core:ShareCapital 2025-01-31 12411051 core:RetainedEarningsAccumulatedLosses 2026-01-31 12411051 core:RetainedEarningsAccumulatedLosses 2025-01-31 12411051 dpl:Item1 2025-02-01 12411051 dpl:Item1 2026-01-31 12411051 dpl:Item1 2024-02-01 12411051 dpl:Item1 2025-01-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12411051
England and Wales
WELLTHY CLINIC LTD
Unaudited Financial Statements
Period of accounts Start date: 01 February 2025 End date: 31 January 2026

Wellthy Clinic Ltd Contents Page For the year ended 31 January 2026
Company Information | 1
Directors' Report | 2
Statement of Financial Position | 3
Notes to the Financial Statements | 4

Wellthy Clinic Ltd Company Information For the year ended 31 January 2026
Directors | Mathew James Glithero Eleonora Sansoni
Registered Number | 12411051
Registered Office | Unit 15 City Business Centre Lower Road London SE16 2XB
Accountants | Cocke Vellacott & Hill Chartered Accountants Unit 15 City Business Centre Lower Road London SE16 2XB
Bankers | Tide Bank
1

Wellthy Clinic Ltd Directors' Report For the year ended 31 January 2026
Director's report and financial statements The directors present report and unaudited accounts for the year ended 31 January 2026. Principal activities The principal activity of the company during the financial year was of Osteopathy, Cranial Osteopathy, Studio Pilates, Nutrition & Sports Massage. Directors The directors who served the company throughout the year were as follows:
Mathew James Glithero
Eleonora Sansoni
Statement of directors' responsibilities The directors are responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice. Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (Financial Reporting Standard 102). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the directors are required to : select suitable accounting policies and then apply them consistently make judgements and accounting estimates that are reasonable and prudent state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions Small company regime This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime with Part 15 of the Companies Act 2006. Audit exemption Wellthy Clinic Ltd has taken advantage of the exemption under Section 477 of the Companies Act 2006 and these financial statements are therefore unaudited. This report was approved by the board and signed on its behalf by:
---------------------------------- Mathew James Glithero Director
Date approved: 10 July 2026 2

Registered Number: 12411051 Wellthy Clinic Ltd Statement of Financial Position As at 31 January 2026
| Notes | 2026 £ |  | 2025 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 158 |  | 353
|  | 158 |  | 353
Current assets |  |  |
Debtors | 4 | 18,251 |  | 14,418
Cash at bank and in hand |  | 24,141 |  | 25,751
|  | 42,392 |  | 40,169
Creditors: amount falling due within one year | 5 | (40,955) |  | (36,026)
Net current assets |  | 1,437 |  | 4,143
Total assets less current liabilities |  | 1,595 |  | 4,496
Net assets |  | 1,595 |  | 4,496
Capital and reserves |  |  |
Called up share capital | 6 | 100 |  | 100
Profit and loss account |  | 1,495 |  | 4,396
Shareholders' funds |  | 1,595 |  | 4,496
For the year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the board of directors on 10 July 2026 and were signed on its behalf by:
------------------------------- Mathew James Glithero Director
3

Wellthy Clinic Ltd Notes to the Financial Statements For the year ended 31 January 2026
General Information Wellthy Clinic Ltd is a private company, limited by shares, registered in England and Wales, registration number 12411051, registration address Unit 15 City Business Centre, Lower Road, London, SE16 2XB.The principal activity of the company during the financial year was of Osteopathy, Cranial Osteopathy, Studio Pilates, Nutrition & Sports Massage. The presentation currency is £ sterling. These financial statements are for the year ended 31 January 2026. The comparative figures are for year to 31 January 2025.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 Section 1A The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared on the going concern basis and under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Revenue recognitioin Revenue is measured at the fair value of the consideration received or receivable and represents the amount receivable for goods supplied or services rendered by the company, net of Value Added Tax and trade discounts. Operating lease rentals Rentals payable under operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account on a straight line basis over the lease term. Taxation Taxation represents the sum of tax currently payable and deferred tax. Current tax is recognised for the amount of income tax payable in respect of the taxable profit for the current or past years and it is calculated using tax rates that have been enacted or substantially enacted by the end of the reporting period. Deferred tax is recognised on all timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profits. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Dividends Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles | 33.33% Reducing Balance
Computer Equipment | 25% Straight Line
Pensions The company contributes to pension arrangements on behalf of its employees. Contributions payable for the year are charged in the income statement.
2. | Average number of employees The company was administered by its directors. Average number of employees during the year was 2 (2025 : 2).
3. | Tangible fixed assets
Cost or valuation | Motor Vehicles |  | Computer Equipment |  | Total
| £ |  | £ |  | £
At 01 February 2025 | 1,075 |  | 2,868 |  | 3,943
Additions | - |  | - |  | -
Disposals | - |  | - |  | -
At 31 January 2026 | 1,075 |  | 2,868 |  | 3,943
Depreciation
At 01 February 2025 | 839 |  | 2,751 |  | 3,590
Charge for year | 78 |  | 117 |  | 195
On disposals | - |  | - |  | -
At 31 January 2026 | 917 |  | 2,868 |  | 3,785
Net book values
Closing balance as at 31 January 2026 | 158 |  | - |  | 158
Opening balance as at 01 February 2025 | 236 |  | 117 |  | 353
4. | Debtors: amounts falling due within one year
| 2026 £ |  | 2025 £
--- | --- | --- | ---
Trade Debtors | 11,374 |  | 8,133
Prepayments & Accrued Income | 6,485 |  | 5,400
Other Debtors | 392 |  | 885
| 18,251 |  | 14,418
5. | Creditors: amount falling due within one year
| 2026 £ |  | 2025 £
--- | --- | --- | ---
Corporation Tax | 12,527 |  | 9,892
Accrued Expenses | 6,277 |  | 9,344
Deferred income | 13,164 |  | 14,666
Other Creditors | 3,670 |  | -
Wages & Salaries Control Account | 63 |  | 63
Pensions control account | 800 |  | 800
VAT | 4,454 |  | 1,261
| 40,955 |  | 36,026
6. | Share Capital Authorised 100 Class A shares of £1.00 each
Allotted, called up and fully paid | 2026 £ |  | 2025 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
7. | Other commitments At 31 January 2026 the company had the following future minimum lease payments under non-cancellable operation leases for each of the following periods:
Payments due |  | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Not later than one year |  | 16,200 |  | 16,200
|  | 16,200 |  | 16,200
8. | Pension commitments The company implements auto-enrolment using a NEST scheme and contributes to pension contributions on behalf of its employees. At the year end there were unpaid contributions of £800 (2025 - £800) due to NEST and included in creditors.
4